Prognostic significance of pretreatment thrombocytosis in endometrial cancer: an Israeli Gynecologic Oncology Group study.
Ori TalRam EitanOfer GemerLimor HelpmanZvi VakninSofia LeytesOfer LavieAlon Ben-ArieAmnon AmitAhmet NamazovInbar Ben ShaharIlan AtlasIlan BruchimTally LevyPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2022)
Pretreatment thrombocytosis is an independent prognostic factor for decreased disease-specific survival and overall survival among patients with endometrial cancer, and can serve as a predictor of poor outcome.